Home
>
National Drug Code (NDC)
>
RELNATE DHA
RELNATE DHA - 35573-103-05 - (OMEGA-3 FATTY ACIDS, THIAMINE MONONITRATE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, FOLIC ACID, CHOLECALCIFEROL, ASCORBIC ACID, ALPHA-TOCOPHEROL, CUPRIC SULFATE ANHYDROUS, ZINC OXIDE, IRO)
Drug Information of RELNATE DHA
| Product NDC: | 35573-103 |
| Proprietary Name: | RELNATE DHA |
| Non Proprietary Name: | OMEGA-3 FATTY ACIDS, THIAMINE MONONITRATE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, FOLIC ACID, CHOLECALCIFEROL, ASCORBIC ACID, ALPHA-TOCOPHEROL, CUPRIC SULFATE ANHYDROUS, ZINC OXIDE, IRO |
| Active Ingredient(s): | 30; 100; 400; 1; 15; 1; 28; 30; 200; 20; 3; 3; 20 [iU]/1; mg/1; [iU]/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1 & nbsp; OMEGA-3 FATTY ACIDS, THIAMINE MONONITRATE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, FOLIC ACID, CHOLECALCIFEROL, ASCORBIC ACID, ALPHA-TOCOPHEROL, CUPRIC SULFATE ANHYDROUS, ZINC OXIDE, IRO |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, LIQUID FILLED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of RELNATE DHA
| Product NDC: | 35573-103 |
| Labeler Name: | Burel Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20110515 |
Package Information of RELNATE DHA
| Package NDC: | 35573-103-05 |
| Package Description: | 1 BOTTLE in 1 CARTON (35573-103-05) > 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (35573-103-30) |
NDC Information of RELNATE DHA
| NDC Code | 35573-103-05 |
| Proprietary Name | RELNATE DHA |
| Package Description | 1 BOTTLE in 1 CARTON (35573-103-05) > 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (35573-103-30) |
| Product NDC | 35573-103 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | OMEGA-3 FATTY ACIDS, THIAMINE MONONITRATE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, FOLIC ACID, CHOLECALCIFEROL, ASCORBIC ACID, ALPHA-TOCOPHEROL, CUPRIC SULFATE ANHYDROUS, ZINC OXIDE, IRO |
| Dosage Form Name | CAPSULE, LIQUID FILLED |
| Route Name | ORAL |
| Start Marketing Date | 20110515 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | Burel Pharmaceuticals, LLC |
| Substance Name | ALPHA-TOCOPHEROL; ASCORBIC ACID; CHOLECALCIFEROL; CUPRIC SULFATE ANHYDROUS; CYANOCOBALAMIN; FOLIC ACID; IRON; MAGNESIUM; OMEGA-3 FATTY ACIDS; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE MONONITRATE; ZINC OXIDE |
| Strength Number | 30; 100; 400; 1; 15; 1; 28; 30; 200; 20; 3; 3; 20 |
| Strength Unit | [iU]/1; mg/1; [iU]/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1 |
| Pharmaceutical Classes | Fatty Acids, Omega-3 [Chemical/Ingredient],Omega-3 Fatty Acid [EPC],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC],Vitamin D [Chemical/Ingredient],Vitamin D [EPC] |
